Cited by 300Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 268 of the 278 references it cites were found in a registry or an index; none of the 298 sources its claims cite is checked for support yet.

Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications

Open access
Yan, Zhen, Rein, Benjamin·2022·Molecular Psychiatry

Abstract

The prefrontal cortex (PFC) serves as the chief executive officer of the brain, controlling the highest level cognitive and emotional processes. Its local circuits among glutamatergic principal neurons and GABAergic interneurons, as well as its long-range connections with other brain regions, have been functionally linked to specific behaviors, ranging from working memory to reward seeking. The efficacy of synaptic signaling in the PFC network is profundedly influenced by monoaminergic inputs via the activation of dopamine, adrenergic, or serotonin receptors. Stress hormones and neuropeptides also exert complex effects on the synaptic structure and function of PFC neurons. Dysregulation of PFC synaptic transmission is strongly linked to social deficits, affective disturbance, and memory loss in brain disorders, including autism, schizophrenia, depression, and Alzheimer's disease. Critical neural circuits, biological pathways, and molecular players that go awry in these mental illnesses have been revealed by integrated electrophysiological, optogenetic, biochemical, and transcriptomic studies of PFC. Novel epigenetic mechanism-based strategies are proposed as potential avenues of therapeutic intervention for PFC-involved diseases. This review provides an overview of PFC network organization and synaptic modulation, as well as the mechanisms linking PFC dysfunction to the pathophysiology of neurodevelopmental, neuropsychiatric, and neurodegenerative diseases. Insights from the preclinical studies offer the potential for discovering new medical treatments for human patients with these brain disorders.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41380-021-01092-3

Cites

268 of 268 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 298 cited sources checked · 0 supported · 0 flagged

Show all 172 claims

  • Probably not a substantial claim. 7
  • It may state two separate claims as one. 79
86 of 86
  • The paper relies on this without support.

    PFC is the last portion of the brain to fully develop.

    “PFC is the last portion of the brain to fully develop.”
  • The paper relies on this without support.

    Human PFC is delineated into two functionally, morphologically, and evolutionarily different regions: ventromedial PFC and lateral PFC.

    “PFC of humans is delineated into two functionally, morphologically, and evolutionarily different regions: ventromedial PFC and lateral PFC.”
  • The paper relies on this without support.

    Most clinically effective antipsychotic drugs, antidepressants and anxiolytics exert potent effects on the serotonin system.

    “Most clinically effective antipsychotic drugs, antidepressants and anxiolytics all exert potent effects on the serotonin system.”
  • The paper relies on this without support.

    Autism is a prevalent neurodevelopmental disorder characterized by core symptoms like social deficits and stereotypic behaviors.

    “Autism is a prevalent neurodevelopmental disorder characterized by core symptoms like social deficits and stereotypic behaviors.”
  • The paper relies on this without support.

    Many of the high-level executive functions controlled by PFC are impaired in autism.

    “Many of the high-level executive functions controlled by PFC are impaired in autism.”
  • The paper relies on this without support.

    Neuropeptide Y is a stress modulatory transmitter associated with PTSD.

    “Neuropeptide Y (NPY), a stress modulatory transmitter, has been associated with PTSD.”
  • The paper relies on this without support.

    PFC is one of the first regions affected in clinical Alzheimer's disease.

    “PFC is one of the first regions to be affected in clinical AD, which may explain the early occurrence of the impairment of PFC-mediated cognitive processes, such as working memory and attention.”
  • The paper relies on this without support.

    Aging is the leading risk factor for developing Alzheimer's disease.

    “Aging is the leading risk factor for developing AD, so many studies have focused on revealing neurobiological changes that affect synaptic integrity with aging and why aged brain is vulnerable to AD.”
  • The paper relies on this without support.

    Findings from animal models of neuropsychiatric and neurodegenerative disorders can be generalized to human patients.

    “Studies in animal models have revealed critical neural circuits, biological pathways, and molecular players that converge to control the excitatory and inhibitory signals in PFC networks.”
9 of 9

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 278 references

10 of the 278 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 101–101 of 101

  • Beyond Stigma–Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery

    Blum, K., Gold, M., Jafari, N., Lewandrowski, K.-U., Sharafshah, A., Mohankumar, K., Lorio, M., Bowirrat, A., Pinhasov, A., Thanos, K., et al. (2026) · Psychology Research and Behavior Management · doi:10.2147/prbm.s561157 · Cited by 1

    “20 A major advance in mapping genes implicated in addiction and reward deficiency syndromes has been led by Blum et al. Their pharmacogenomic research using the Genetic Addiction Risk Score (GARS) employed a multi-layered in silico approach encompassing: (1) Protein–Protein Interactions (PPIs), (2)…”

Metadata

Authors
Yan, Z., & Rein, B.
Affiliations
University at Buffalo, State University of New York (US)
Corresponding author
Yan, Zhen
Venue
Molecular Psychiatry
Published
2021-04-19
Volume
27
Issue
1
Pages
445-465
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W3154550139
Cited by
300
References
278
Citations by year
2026: 54 · 2025: 78 · 2024: 60 · 2023: 56 · 2022: 39 · 2021: 13
FWCI
6.41
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH108842)
  • U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG056060)
  • U.S. Department of Health & Human Services | National Institutes of Health (AG064656, AG067597)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
prefrontal cortex, synaptic transmission, GABAergic interneurons, dopamine, serotonin, stress hormones, neuropeptides, autism spectrum disorder, schizophrenia, depression, Alzheimer's disease, social dysfunction, memory loss, epigenetic therapy, neuropsychiatric disorders, neurodevelopmental disorders, neurodegenerative diseases
MeSH terms
Humans, Interneurons, Memory, Short-Term, Synaptic Transmission, Neurons, Prefrontal Cortex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review